The drug price regulator has slashed prices of 43 commonly used essential medicines by up to 35%, a move expected to benefit patients suffering from several critical diseases and who need expensive medicines.
The National Pharmaceutical Pricing Authority reduced prices of drugs used in treatment of ailments like diabetes, cancer, asthma, cardiovascular diseases, mental disorders and kidney failure.
Prices have been revised under three different categories. While some new drugs have been brought under price control, the regulator has also further slashed prices of around 30 drugs which were already under price control. The regulator has also allowed a slight increase in prices of two medicines based on review order issued by the pharmaceuticals department.
Apr 03, 2017 0